Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance (Q57904816)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance	No description defined

Statements

scholarly article

0 references

Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

George Papatheodoridis

object named as

G. Papatheodoridis

11

0 references

Athanasios Dimopoulos

15

object named as

M.A. Dimopoulos

0 references

author name string

A. Bamias

1

0 references

M.L. Tsiatas

2

0 references

E. Kafantari

3

0 references

C. Liakou

4

0 references

A. Rodolakis

5

0 references

Z. Voulgaris

6

0 references

G. Vlahos

7

0 references

T. Papageorgiou

8

0 references

O. Tsitsilonis

9

0 references

C. Bamia

10

0 references

Ek. Politi

12

0 references

A. Archimandritis

13

0 references

A. Antsaklis

14

0 references

language of work or name

0 references

publication date

July 2007

0 references

Gynecologic Oncology

0 references

106

0 references

1

0 references

75-81

0 references

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Ovarian cancer: epidemiology, biology, and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Second-line treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Cytokine-induced Killer Cells: NK-like T Cells with Cytotolytic Specificity against Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.029

7 January 2021

Identifiers

10.1016/J.YGYNO.2007.02.029

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57904816&oldid=1783658319"